catechin and 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol

catechin has been researched along with 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amit, T; Avramovich-Tirosh, Y; Mandel, S; Youdim, MB	1

Reviews

1 review(s) available for catechin and 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol

Article	Year
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:5 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cell Cycle; Humans; Hydroxyquinolines; Iron; Iron Chelating Agents; Neurodegenerative Diseases; Neuroprotective Agents; PC12 Cells; Piperazines; Rats	2008

Article

Year

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:5

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cell Cycle; Humans; Hydroxyquinolines; Iron; Iron Chelating Agents; Neurodegenerative Diseases; Neuroprotective Agents; PC12 Cells; Piperazines; Rats

2008